I received a reply from the CEO Friday afternoon, As I anticipated the content was restrictive in nature.
In reply to my question regarding Ezcorp's on-market creep purchase and strategic intend behind their actions as a holder on the register, Sam explained it's the solely a matter for Ezcorp and the CCV board cannot offer an opinion pertaining to it. No surprise there.
As far as the holdings of Mr Lachlan Given and Mr Timothy Jugmans, he provided links to the most recent EZCORP Statement of Changes in Beneficial Ownership.
I couldn't find details relating to their indirect holdings in CCV.
All content he provided is available on the Ezcorp website under the Investors Relation Section. Here is a comment from Ezcorp made by the Ezcorp CEO during an investor day held in March 2022 .
“On Cash Converters, we often get questions on this one. Cash Converters is obviously Australia’s leading lending business for this customer demographic. They’ve got 18 countries franchised. But what we love about Cash Converters is it’s a similar business to us. It’s not identical, but it’s got a super strong management team. It’s trading at a very low multiple. And we think that this management team has significantly cleaned it up so that it’s got this sort of positioning for real growth. So, it’s a core part of what we do, and we’re excited about that and particularly about the management team…”
In all honesty I didn't expect more but it was worth a try. Looks like we're going to come under the Ezcorp umbrella in 18 months.
I have no idea what will transpire after that. I'm hoping the board can increase the dividend as it's an attractive yield at the moment, it will be stellar if it jumps to 4c a year fully franked.
- Forums
- ASX - By Stock
- CCV
- Ann: Change in substantial holding
Ann: Change in substantial holding, page-13
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
First paediatric clinical site activated – major recruitment milestone and key appointment announced
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
Add CCV (ASX) to my watchlist
|
|||||
Last
21.5¢ |
Change
-0.010(4.44%) |
Mkt cap ! $134.9M |
Open | High | Low | Value | Volume |
21.0¢ | 21.5¢ | 20.5¢ | $169.0K | 804.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 117781 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 703718 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 117781 | 0.210 |
5 | 127340 | 0.205 |
11 | 344405 | 0.200 |
2 | 25512 | 0.195 |
6 | 1288000 | 0.190 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 703718 | 2 |
0.220 | 360000 | 3 |
0.225 | 205000 | 2 |
0.230 | 492054 | 4 |
0.235 | 154000 | 2 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
CCV (ASX) Chart |